Search results
Jump to navigation
Jump to search
Page title matches
- ...age|Aromatase CytP450 with androstenedione.png|right|350px|Human placental aromatase bound to ligands [[androstenedione]] (cyan) and [[heme]] (yellow). Coordina '''Aromatase''', the 503-amino acid long [[protein]] product of the ''CYP19A1'' [[gene]]3 KB (342 words) - 17:25, 31 May 2009
- 12 bytes (1 word) - 16:44, 30 May 2009
- #REDIRECT [[Aromatase inhibitor]]33 bytes (3 words) - 17:37, 31 May 2009
- | pagename = Aromatase | abc = aromatase734 bytes (62 words) - 16:46, 30 May 2009
- #REDIRECT [[Talk:Aromatase inhibitor]]38 bytes (4 words) - 17:37, 31 May 2009
- 144 bytes (18 words) - 16:45, 30 May 2009
- ...ree AIs are approved by the FDA<ref>[http://www.cancernet.gov/cancertopics/aromatase-inhibitors CancerNet]</ref> :610 bytes (69 words) - 03:15, 7 October 2013
- 12 bytes (1 word) - 17:37, 31 May 2009
- 139 bytes (14 words) - 17:37, 31 May 2009
- {{r|aromatase inhibitor}}206 bytes (25 words) - 17:32, 31 May 2009
File:Aromatase CytP450 with androstenedione.png (1,060 × 674 (287 KB)) - 19:51, 11 March 2022- * [http://www.cancernet.gov/cancertopics/aromatase-inhibitors aromatase-inhibitors at CancerNet]109 bytes (10 words) - 17:35, 31 May 2009
- #REDIRECT [[Aromatase inhibitor/Definition]]44 bytes (4 words) - 17:37, 31 May 2009
- #REDIRECT [[Template:Aromatase inhibitor/Metadata]]51 bytes (5 words) - 17:38, 31 May 2009
- | pagename = aromatase inhibitor | abc = aromatase inhibitor762 bytes (65 words) - 19:01, 2 July 2010
- 37 bytes (6 words) - 04:04, 6 June 2009
- Auto-populated based on [[Special:WhatLinksHere/Aromatase inhibitor]]. Needs checking by a human. {{r|Aromatase}}508 bytes (66 words) - 11:03, 11 January 2010
Page text matches
- ...ree AIs are approved by the FDA<ref>[http://www.cancernet.gov/cancertopics/aromatase-inhibitors CancerNet]</ref> :610 bytes (69 words) - 03:15, 7 October 2013
- #REDIRECT [[Aromatase inhibitor]]33 bytes (3 words) - 17:37, 31 May 2009
- #REDIRECT [[Talk:Aromatase inhibitor]]38 bytes (4 words) - 17:37, 31 May 2009
- #REDIRECT [[Aromatase inhibitor/Definition]]44 bytes (4 words) - 17:37, 31 May 2009
- | pagename = Aromatase | abc = aromatase734 bytes (62 words) - 16:46, 30 May 2009
- * [http://www.cancernet.gov/cancertopics/aromatase-inhibitors aromatase-inhibitors at CancerNet]109 bytes (10 words) - 17:35, 31 May 2009
- #REDIRECT [[Template:Aromatase inhibitor/Metadata]]51 bytes (5 words) - 17:38, 31 May 2009
- | pagename = aromatase inhibitor | abc = aromatase inhibitor762 bytes (65 words) - 19:01, 2 July 2010
- Auto-populated based on [[Special:WhatLinksHere/Aromatase inhibitor]]. Needs checking by a human. {{r|Aromatase}}508 bytes (66 words) - 11:03, 11 January 2010
- ...age|Aromatase CytP450 with androstenedione.png|right|350px|Human placental aromatase bound to ligands [[androstenedione]] (cyan) and [[heme]] (yellow). Coordina '''Aromatase''', the 503-amino acid long [[protein]] product of the ''CYP19A1'' [[gene]]3 KB (342 words) - 17:25, 31 May 2009
- {{r|Aromatase inhibitor}} {{r|Aromatase}}819 bytes (107 words) - 20:53, 11 January 2010
- {{r|Aromatase}} {{r|Aromatase inhibitor||**}}1 KB (156 words) - 08:01, 16 April 2010
- {{r|aromatase inhibitor}}206 bytes (25 words) - 17:32, 31 May 2009
- {{r|Aromatase}}548 bytes (71 words) - 10:55, 11 January 2010
- {{r|Aromatase}}541 bytes (71 words) - 17:08, 11 January 2010
- {{r|aromatase}}800 bytes (73 words) - 16:38, 30 May 2009
- Until the introduction of the [[aromatase inhibitor]]s, tamoxifen was the gold standard for chemotherapy of [[breast2 KB (211 words) - 19:00, 2 July 2010
- ...lf-limiting. For example, in some of the most recent breast cancer trials, aromatase inhibitors were compared with the existing "gold standard", tamoxifen. The3 KB (445 words) - 03:53, 3 January 2009
- {{r|Aromatase}}4 KB (486 words) - 19:46, 11 January 2010
- ...mones. In the brain, testosterone can also be metabolised (by the enzyme [[aromatase]])to produce [[oestrogen]]. Testosterone has a negative feedback effect on4 KB (522 words) - 21:11, 19 November 2013
- ...erdependent biosynthetic pathways and hormone-receptor interactions, all [[aromatase inhibitor]]s, including but not limited to, [[anastrozole]], [[letrozole]],11 KB (1,234 words) - 07:26, 27 August 2013
- ...erdependent biosynthetic pathways and hormone-receptor interactions, all [[aromatase inhibitor]]s, including but not limited to, [[anastrozole]], [[letrozole]],11 KB (1,231 words) - 15:55, 12 September 2019
- ...duction that occurs at the menopause may lead to an increase in peripheral aromatase activity. Understanding the role of endogenous estrogen metabolites in reg Simpson ER. Role of aromatase in sex steroid action. Journal of Molecular Endocrinology (2000);25: 149-1513 KB (1,805 words) - 02:37, 16 February 2010
- Hormone antagonists and modulators: Needs some physiology (why ban aromatase inhibitors?)8 KB (1,227 words) - 00:09, 6 February 2010
- ...aromatization of circulating [[testosterone]]s, catalysed by the enzyme [[aromatase]]. This occurs at many sites throughout the body, including in adipose tiss ...te of oestrogen production <ref name=Simpson2000>Simpson ER (2000) Role of aromatase in sex steroid action. ''J Mol Endocrinol'' 25:149-56</ref>.20 KB (2,903 words) - 10:11, 24 July 2011
- Hormone antagonists and modulators: Needs some physiology (why ban aromatase inhibitors?)14 KB (2,142 words) - 20:18, 11 August 2011
- ...to ([[estradiol]])<ref>This conversion is by [[aromatisation]]; the enzyme aromatase is expressed in specific neuronal populations</ref>, which is the main acti16 KB (2,283 words) - 09:06, 15 March 2011
- ...ation has only redlinks. There is no detailed discussion of the issues of aromatase inhibitors vs. tamoxifen in pre- and post-menopausal patients.16 KB (2,585 words) - 11:02, 18 August 2015
- ...lest class of steroids, the estrogens, are biosynthesized, by the enzyme [[aromatase]], from the androgens by loss of the C-19 <math>\beta</math>-methyl group,19 KB (2,703 words) - 10:17, 29 March 2023
- ...cated in breast and [[endometrial cancer]]s. Estrogen is produced by the [[aromatase]] enzyme which is present in many tissues including adipose tissue. The pro31 KB (4,537 words) - 09:57, 18 February 2011
- ...drostenedione]] and [[testosterone]] (which can be directly converted by [[aromatase]] to the estrogens [[estrone]] and [[estradiol]], respectively). Increased ...lized, with possible adjuvant hormonal therapy (with [[tamoxifen]] or an [[aromatase inhibitor]]), [[chemotherapy]], and/or [[radiotherapy]]. At present, the tr101 KB (14,716 words) - 09:04, 5 April 2024
- ...ter efficacy, to the standard treatment, from the 5-drug Cooper regimen to aromatase inhibitors. [[User:Howard C. Berkowitz|Howard C. Berkowitz]] 03:32, 15 Octo83 KB (13,126 words) - 15:51, 4 January 2009
- ...he same criteria as would an article on, for example, the statement that [[aromatase inhibitor]]s are more effective in breast cancer than [[tamoxifen]]. It wou73 KB (11,614 words) - 15:53, 4 January 2009
- ...hibitor]]s. Most of these trials, incidentally, were stopped early and the aromatase inhibitors offered to all patients, as their superiority was judged, by ind251 KB (40,897 words) - 17:02, 22 March 2024
- ...fective in patients with that characteristic, and the others should get an aromatase inhibitor, the standard of care. Given there is a treatment, a placebo cont157 KB (24,840 words) - 17:21, 20 September 2010
- :If she had the same diagnosis today, she'd probably go on [[aromatase inhibitor]]s with [[tamoxifen]] as a backup, the drug choice in part being300 KB (47,866 words) - 15:19, 20 March 2023